methyl methanesulfonate has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Chen, DB | 1 |
| Lin, C | 1 |
| Cao, K | 1 |
| Wan, Y | 1 |
| Zhao, XY | 1 |
| Nie, CL | 1 |
| Yuan, Z | 1 |
| Wei, YQ | 1 |
| Paik, J | 1 |
| Duncan, T | 1 |
| Lindahl, T | 1 |
| Sedgwick, B | 1 |
| Smith, DB | 1 |
| Lind, MJ | 1 |
| Kaye, SB | 1 |
| Newlands, ES | 1 |
| Blackledge, GR | 1 |
| Gibson, A | 1 |
3 other studies available for methyl methanesulfonate and Cancer of Ovary
| Article | Year |
|---|---|
hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells.
Topics: Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; Carbon-Nitrogen Lyases; Caspase | 2013 |
Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
Topics: Antineoplastic Agents, Alkylating; Carmustine; Cell Cycle; Dacarbazine; DNA Glycosylases; Female; Ge | 2005 |
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).
Topics: Adult; Aged; Alkylating Agents; Drug Evaluation; Female; Humans; Methyl Methanesulfonate; Middle Age | 1988 |